Tomohiko Kamasako

Chiba Cancer Center

Papers

1

Total Citations

3

H-Index

1

About

Dr. Tomohiko Kamasako is a urologic oncologist whose research focuses on optimizing surgical outcomes for high-risk prostate cancer, particularly through radical prostatectomy. His most impactful work examines the clinical challenges of treating patients with clinical T3 prostate cancer, a locally advanced stage where the effectiveness of surgical intervention has been debated. In his landmark 2018 study, Dr. Kamasako analyzed a large cohort of over 1,400 patients who underwent radical prostatectomy, identifying key predictive factors for biochemical recurrence—a critical marker of cancer progression after surgery. By demonstrating that radical prostatectomy can provide effective cancer control even in this advanced setting, his findings have helped refine patient selection and postoperative monitoring strategies. While his work has garnered modest citation counts, its clinical significance lies in addressing a controversial area of urologic oncology, offering evidence-based guidance for surgeons managing high-risk cases. Dr. Kamasako’s contributions underscore the importance of aggressive surgical management in carefully selected patients, advancing the dialogue on personalized treatment approaches for locally advanced prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Factors predicting biochemical recurrence after radical prostatectomy among patients with clinical T3 prostate cancer
3 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Chiba Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago